Systematic reassessment of reported variants in individuals with suspicion of Alport spectrum disorder reveals a high rate of ambiguous results

Systematic reassessment of reported variants in individuals with suspicion of Alport spectrum disorder reveals a high rate of ambiguous results

Bayer begins phase 2 trial of new Alport syndrome therapy

Bayer begins phase 2 trial of new Alport syndrome therapy

Bayer takes Alport syndrome drug into phase 2

Bayer takes Alport syndrome drug into phase 2